IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.2860
+0.0020 (0.70%)
At close: Mar 27, 2026
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 65.88 million as of March 27, 2026. Its market cap has decreased by -42.11% in one year.
Market Cap
65.88M
Enterprise Value
42.55M
Revenue
53.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 65.88M, an increase of 292.68%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 65.88M | -18.98% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 133.29B |
| Getinge AB | 50.25B |
| Sectra AB | 42.12B |
| Medicover AB | 27.96B |
| Pila Pharma AB | 69.35M |
| Spago Nanomedical AB | 67.48M |
| AcouSort AB | 62.65M |
| Prostatype Genomics AB | 57.77M |